Immune gene networks of mycobacterial vaccine-elicited cellular responses and immunity

Journal of Infectious Diseases

Volumn 195, Issue 1, 2007, Pages 55-69

  Huang, Dan ^a   Qiu, Liyou ^a   Wang, Richard ^a   Lai, Xioamin ^a   Du, George ^a   Seghal, Probhat ^b   Shen, Yun ^a   Shao, Lingyun ^a   Halliday, Lisa ^a   Fortman, Jeff ^a   Shen, Ling ^c   Letvin, Norman L ^c   Chen, Zheng W ^a,d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d MC790 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BCG VACCINE; BETA INTERFERON; CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; GENE PRODUCT; INTERLEUKIN 15; INTERLEUKIN 16; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 3; INTERLEUKIN 3 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BCG VACCINATION; CELLULAR IMMUNITY; GENE EXPRESSION REGULATION; HUMAN; IMMUNE GENE NETWORK; IMMUNE RESPONSE; IMMUNE RESPONSE GENE; IMMUNOGENICITY; MONKEY; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BCG VACCINE; IMMUNITY, CELLULAR; MACACA; MYCOBACTERIUM INFECTIONS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 33845644180     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/509895     Document Type: Article

References (40)

1. Soysal A, Millington KA, Bakir M, et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 2005; 366:1443-51.
2. Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 1994; 271:698-702.
3. Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 1993; 22:1154-8.
4. Moore ZS, Seward JF, Lane JM. Smallpox. Lancet 2006; 367:425-35.
5. Barba-Spaeth G, Longman RS, Albert ML, Rice CM. Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes. J Exp Med 2005; 202:1179-84.
6. Eichner M, Dietz K. Eradication of poliomyelitis: when can one be sure that polio virus transmission has been terminated? Am J Epidemiol 1996; 143:816-22.
7. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282:677-86.
8. Colditz GA, Berkey CS, Mosteller F, et al. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 1995; 96:29-35.
9. Fine PE. BCG: the challenge continues. Scand J Infect Dis 2001; 33:243-5.
10. Orme IM. Tuberculosis vaccines: current progress. Drugs 2005; 65:2437-44.
11. Young D, Dye C. The development and impact of tuberculosis vaccines. Cell 2006; 124:683-7.
12. Tree JA, Elmore MJ, Javed S, Williams A, Marsh PD. Development of a guinea pig immune response-related microarray and its use to define the host response following Mycobacterium bovis BCG vaccination. Infect Immun 2006; 74:1436-41.
13. Mollenkopf HJ, Hahnke K, Kaufmann SH. Transcriptional responses in mouse lungs induced by vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis. Microbes Infect 2006; 8:136-44.
14. Shen Y, Zhou D, Chalifoux L, et al. Induction of an AIDS virus-related tuberculosis-like disease in macaques: a model of simian immunodeficiency virus-mycobacterium coinfection. Infect Immun 2002; 70:869-77.
15. Shen Y, Zhou D, Qiu L, et al. Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science 2002; 295:2255-8.
16. Lai X, Shen Y, Zhou D, et al. Immune biology of macaque lymphocyte populations in a mycobacterial infection. Clin Exp Immunol 2003; 133:182-92.
17. Barclay WR, Busey WM, Dalgard DW, et al. Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin. Am Rev Respir Dis 1973; 107:351-8.
18. Good RC. Biology of the mycobacterioses. Simian tuberculosis: immunologic aspects. Ann NY Acad Sci 1968; 154:200-13.
19. Janicki BW, Good RC, Minden P, Affronti LF, Hymes WF. Immune responses in rhesus monkeys after bacillus Calmette-Guerin vaccination and aerosol challenge with Mycobacterium tuberculosis. Am Rev Respir Dis 1973; 107:359-66.
20. Ribi E, Anacker RL, Barclay WR, et al. Efficacy of mycobacterial cell walls as a vaccine against airborne tuberculosis in the rheusus monkey. J Infect Dis 1971; 123:527-38.
21. Chen ZW, Shen L, Regan JD, Kou Z, Ghim SH, Letvin NL. The T cell receptor gene usage by simian immunodeficiency virus gag-specific cytotoxic T lymphocytes in rhesus monkeys. J Immunol 1996; 156:1469-75.
22. Shen Y, Shen L, Sehgal P, et al. Antiretroviral agents restore Mycobacterium-specific T-cell immune responses and facilitate controlling a fatal tuberculosis-like disease in macaques coinfected with simian immunodeficiency virus and Mycobacterium bovis BCG. J Virol 2001; 75:8690-6.
23. Zhou D, Lai X, Shen Y, et al. Inhibition of adaptive Vgamma2Vdelta2+ T-cell responses during active mycobacterial coinfection of simian immunodeficiency virus SIVmac-infected monkeys. J Virol 2003; 77:2998-3006.
24. + T cells. J Infect Dis 2004; 190:1438-47.
25. Shen Y, Shen L, Sehgal P, et al. Clinical latency and reactivation of AIDS-related mycobacterial infections. J Virol 2004; 78:14023-32.
26. Du G, Qiu L, Shen L, et al. Combined megaplex TCR isolation and SMART-based real-time quantitation methods for quantitating antigen-specific T cell clones in mycobacterial infection. J Immunol Methods 2006; 308:19-35.
27. Molon B, Gri G, Bettella M, et al. T cell costimulation by chemokine receptors. Nat Immunol 2005; 6:465-71.
28. Bachmann MF, Kopf M, Marsland BJ. Chemokines: more than just road signs. Nat Rev Immunol 2006; 6:159-64.
29. Carreno BM, Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2002; 20:29-53.
30. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005; 23:515-48.
31. George MD, Reay E, Sankaran S, Dandekar S. Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T-cell restoration and enhanced gene expression regulating mucosal repair and regeneration. J Virol 2005; 79:2709-19.
32. Bosinger SE, Hosiawa KA, Cameron MJ, et al. Gene expression profiling of host response in models of acute HIV infection. J Immunol 2004; 173:6858-63.
33. Li Q, Schacker T, Carlis J, Beilman G, Nguyen P, Haase AT. Functional genomic analysis of the response of HIV-1-infected lymphatic tissue to antiretroviral therapy. J Infect Dis 2004; 189:572-82.
34. Baskin CR, Garcia-Sastre A, Tumpey TM, et al. Integration of clinical data, pathology, and cDNA microarrays in influenza virus-infected pigtailed macaques (Macaca nemestrina). J Virol 2004; 78:10420-32.
35. Sui Y, Potula R, Pinson D, et al. Microarray analysis of cytokine and chemokine genes in the brains of macaques with SHIV-encephalitis. J Med Primatol 2003; 32:229-39.
36. Chen ZW, Shen Y, Zhou D, et al. In vivo T-lymphocyte activation and transient reduction of viral replication in macaques infected with simian immunodeficiency virus. J Virol 2001; 75:4713-20.
37. Giavedoni LD, Velasquillo MC, Parodi LM, Hubbard GB, Hodara VL. Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus. J Virol 2000; 74:1648-57.
38. Kwofie TB, Haga T, Iida T, Hayami M, Miura T. Cytokine kinetics in the plasma of monkeys infected with pathogenic and nonpathogenic simian and human immunodeficiency chimeric viruses at an early stage of infection. Microbiol Immunol 2001; 45:399-402.
39. Way SS, Wilson CB. Cutting edge: immunity and IFN-gamma production during Listeria monocytogenes infection in the absence of T-bet. J Immunol 2004; 173:5918-22.
40. Koguchi K, Anderson DE, Yang L, O'Connor KC, Kuchroo VK, Hafler DA. Dysregulated T cell expression of TIM3 in multiple sclerosis. J Exp Med 2006; 203:1413-8.